FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jorge Plutzky

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Mouse

Physiology

Transcription, Genetic

Co-author Network

Publications

TOP 3
Huabing Zhang; Perry Mar; Fritha Morrison; Jorge Plutzky; Maria Shubina; Stephen Skentzos; Alexander Turchin
Discontinuation of statins in routine care settings: a cohort study.
Sarah D de Ferranti; Matthew Gillman; Jorge Plutzky; Louis Vernacchio; Stephen R Daniels; Annette L Baker
NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood?
Robert S Rosenson; R Scott Wright; Michael Farkouh; Jorge Plutzky
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jorge Plutzky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Huabing Zhang; Perry Mar; Fritha Morrison; Jorge Plutzky; Maria Shubina; Stephen Skentzos; Alexander Turchin
Discontinuation of statins in routine care settings: a cohort study.
Annals of internal medicine 2013;158(7):526-34.
2012: Sarah D de Ferranti; Matthew Gillman; Jorge Plutzky; Louis Vernacchio; Stephen R Daniels; Annette L Baker
NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood?
Clinical chemistry 2012;58(12):1626-30.
2012: Robert S Rosenson; R Scott Wright; Michael Farkouh; Jorge Plutzky
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.
American heart journal 2012;164(5):672-80.
2012: Harun Elmasri; Elisa Ghelfi; Gokhan Hotamisligil; Jorge Plutzky; Mustafa Sahin; Guo-Ping Shi; Samantha Traphagen; Chen-wei Yu; Haiming Cao; Manuela Cernadas; Sule Cataltepe
Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway.
Angiogenesis 2012;15(3):457-68.
2012: Florian W Kiefer; Paul Cohen; Jorge Plutzky
Fifty shades of brown: perivascular fat, thermogenesis, and atherosclerosis.
Circulation 2012;126(9):1012-5.
2012: Florian W Kiefer; Philip Luger; Shriram Nallamshetty; Gabriela Orasanu; Jonathan D Brown; Charles F Burant; Gregg Duester; Nathan R Qi; Hong Wang; Jorge Plutzky
Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism.
Endocrinology 2012;153(7):3089-99.
2012: Eun-Jung Rhee; Jorge Plutzky
Retinoid metabolism and diabetes mellitus.
Diabetes & metabolism journal 2012;36(3):167-80.
2012: Janet Lo; Jorge Plutzky
The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients.
The Journal of infectious diseases 2012;205 Suppl 3():S368-74.
2012: Florian W Kiefer; Shriram Nallamshetty; Patrick O'Brien; Steffen Spoerl; Thomas M Stulnig; Cecile VERNOCHET; Maximilian Zeyda; Jonathan D Brown; David E Cohen; C Ronald Kahn; Jorge Plutzky
Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue.
Nature medicine 2012;18(6):918-25.
2012: Mohit Jain; Jorge Plutzky
Commentary.
Clinical chemistry 2012;58(5):829-30.
2012: Bradley W Blaser; Corey Cutler; Vincent T Ho; Haesook T Kim; John Koreth; Jorge Plutzky; Edwin P Alyea; Joseph H Antin; Philippe Armand; Robert J Soiffer
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):575-83.
2011: Jorge Plutzky
The incretin axis in cardiovascular disease.
Circulation 2011;124(21):2285-9.
2011: Jorge Plutzky
Macrovascular effects and safety issues of therapies for type 2 diabetes.
The American journal of cardiology 2011;108(3 Suppl):25B-32B.
2011: Michael H Davidson; Jorge Plutzky
The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction.
The American journal of cardiology 2011;108(3 Suppl):1B-2B.
2011: Jung Hoon Lee; Jorge Plutzky; Jian Wang; Jonathan D Brown; Stephen A Duncan; Petros Giannikopoulos; Laurie H Glimcher; Robert A Hegele; Christopher T Johansen; Ann-Hwee Lee
The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.
Nature medicine 2011;17(7):812-5.
2011: Jorge Plutzky
The PPAR-RXR transcriptional complex in the vasculature: energy in the balance.
Circulation research 2011;108(8):1002-16.
2011: Elena V Shabrova; Ajay P Singh; Olga Tarnopolsky; Nicholi Vorsa; Jorge Plutzky; Loredana Quadro
Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice.
PloS one 2011;6(10):e24634.
2011: Jonathan D Brown; Eric Oligino; Daniel J Rader; Alan Saghatelian; Jorge Plutzky
VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses.
PloS one 2011;6(7):e21209.
2010: Kiyuk Chang; Sanjeev A Francis; Elena Aikawa; Jose-Luiz Figueiredo; Rainer H Kohler; Jason R McCarthy; Ralph Weissleder; Jorge Plutzky; Farouc A Jaffer
Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(10):1933-9.
2010: Maxwell A Ruby; Benjamin Goldenson; Gabriela Orasanu; Thomas P Johnston; Jorge Plutzky; Ronald M Krauss
VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids.
Journal of lipid research 2010;51(8):2275-81.
2010: Vivian A Fonseca; Bernard Zinman; Michael A Nauck; Allison B Goldfine; Jorge Plutzky
Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies.
The American journal of medicine 2010;123(7):S2-S10.
2010: William A Chutkow; Andreas L Birkenfeld; Jonathan D Brown; Hui-Young Lee; David W Frederick; Jun Yoshioka; Parth Patwari; Romy Kursawe; Samuel W Cushman; Jorge Plutzky; Gerald I Shulman; Varman T Samuel; Richard T Lee
Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.
Diabetes 2010;59(6):1424-34.
2010: Jonthan Brown; Shriram Nallamshetty; Jorge Plutzky
Intersecting vectors of basic science research and clinical medicine: LOX-1?
Clinical chemistry 2010;56(4):499-501.
2009: Jorge Plutzky
Expansion and contraction: the mighty, mighty fatty acid.
Nature medicine 2009;15(6):618-9.
2009: Gabriela Orasanu; Jorge Plutzky
The pathologic continuum of diabetic vascular disease.
Journal of the American College of Cardiology 2009;53(5 Suppl):S35-42.
2009: Takeshi Kanda; Jonathan D Brown; Gabriela Orasanu; Silke Vogel; Frank J Gonzalez; Juliano Sartoretto; Thomas Michel; Jorge Plutzky
PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.
The Journal of clinical investigation 2009;119(1):110-24.
2008: Jean-Charles Fruchart; Frank Sacks; Michel P Hermans; Gerd Assmann; W Virgil Brown; Richard Ceska; M John Chapman; Paul M Dodson; Paola Fioretto; Henry N Ginsberg; Takashi Kadowaki; Jean-Marc LaBlanche; Nikolaus Marx; Jorge Plutzky; Zeljko Reiner; Robert S Rosenson; Bart Staels; Jane K Stock; Rody Sy; Christoph Wanner; Alberto Zambon; Paul Zimmet
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
The American journal of cardiology 2008;102(10 Suppl):1K-34K.
2008: Jean-Charles Fruchart; Frank M Sacks; Michel P Hermans; Gerd Assmann; W Virgil Brown; Richard Ceska; M John Chapman; Paul M Dodson; Paola Fioretto; Henry N Ginsberg; Takashi Kadowaki; Jean-Marc LaBlanche; Nikolaus Marx; Jorge Plutzky; Zeljko Reiner; Robert S Rosenson; Bart Staels; Jane K Stock; Rody Sy; Christoph Wanner; Alberto Zambon; Paul Zimmet
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(4):319-35.
2008: Gabriela Orasanu; Ouliana Ziouzenkova; Pallavi R Devchand; Vedika Nehra; Osama Hamdy; Edward S Horton; Jorge Plutzky
The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
Journal of the American College of Cardiology 2008;52(10):869-81.
2008: Sailaja Paruchuri; Yongfeng Jiang; Chunli Feng; Sanjeev A Francis; Jorge Plutzky; Joshua A Boyce
Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.
The Journal of biological chemistry 2008;283(24):16477-87.
2008: Theodore Mazzone; Alan Chait; Jorge Plutzky
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.
Lancet 2008;371(9626):1800-9.
2008: Ouliana Ziouzenkova; Jorge Plutzky
Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.
FEBS letters 2008;582(1):32-8.
2008: Takeshi Kanda; Shu Wakino; Koichi Hayashi; Jorge Plutzky
Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
Journal of the American Society of Nephrology : JASN 2008;19(1):4-7.
2007: Jorge Plutzky
A cardiologist's perspective on cardiometabolic risk.
The American journal of cardiology 2007;100(12A):3P-6P.
2007: Jorge Plutzky
Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalpha.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007;4 Suppl 3():S12-4.
2007: W Ahmed; Ouliana Ziouzenkova; J Brown; Pallavi R Devchand; S Francis; M Kadakia; T Kanda; Gabriela Orasanu; M Sharlach; F Zandbergen; Jorge Plutzky
PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Journal of internal medicine 2007;262(2):184-98.
2007: Fokko Zandbergen; Jorge Plutzky
PPARalpha in atherosclerosis and inflammation.
Biochimica et biophysica acta 2007;1771(8):972-82.
2007: Ouliana Ziouzenkova; Gabriela Orasanu; Molly Sharlach; Taro E Akiyama; Joel P Berger; Jason Viereck; James A Hamilton; Guangwen Tang; Gregory G Dolnikowski; Silke Vogel; Gregg Duester; Jorge Plutzky
Retinaldehyde represses adipogenesis and diet-induced obesity.
Nature medicine 2007;13(6):695-702.
2007: Peter Libby; Jorge Plutzky
Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
The American journal of cardiology 2007;99(4A):27B-40B.
2007: Jonathan D Brown; Jorge Plutzky
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Circulation 2007;115(4):518-33.
2007: John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael Pignone; Jorge Plutzky; Daniel Porte; Rita F Redberg; Kimberly F Stitzel; Neil stone
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Circulation 2007;115(1):114-26.
2007: John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael Pignone; Jorge Plutzky; Daniel Porte; Rita F Redberg; Kimberly F Stitzel; Neil stone
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Diabetes care 2007;30(1):162-72.
2007: Ouliana Ziouzenkova; Gabriela Orasanu; Galina Sukhova; Evan Lau; Joel P Berger; Guangwen Tang; Norman I Krinsky; Gregory G Dolnikowski; Jorge Plutzky
Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses.
Molecular endocrinology (Baltimore, Md.) 2007;21(1):77-88.
2006: Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.
Circulation 2006;114(25):2871-91.
2006: Victor J Dzau; Elliott M Antman; Henry R Black; David L Hayes; JoAnn E Manson; Jorge Plutzky; Jeffrey J Popma; William Stevenson
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
Circulation 2006;114(25):2850-70.
2006: Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Pharmacological reviews 2006;58(4):726-41.
2006: Chang Yeop Han; Tsuyoshi Chiba; Jean S Campbell; Nelson Fausto; Michelle L Chaisson; Gabriela Orasanu; Jorge Plutzky; Alan Chait
Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(8):1806-13.
2006: Waleed Ahmed; Gabriela Orasanu; Vedika Nehra; Liana Asatryan; Daniel J Rader; Ouliana Ziouzenkova; Jorge Plutzky
High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.
Circulation research 2006;98(4):490-8.
2006: Chih-Hao Lee; Jorge Plutzky
Liver X receptor activation and high-density lipoprotein biology: a reversal of fortune?
Circulation 2006;113(1):5-8.
2005: Graham T McMahon; Jorge Plutzky; Edouard Daher; Tammy Bhattacharyya; George Grunberger; Marcelo F Dicarli
Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes.
Diabetes care 2005;28(5):1145-50.
2005: Andrew J Drexler; Richard W Nesto; Martin J Abrahamson; George L Bakris; David Bell; John Brunzell; Paresh Dandona; Jaime Davidson; Vivian Fonseca; Michael Fowler; Robert Frye; Thomas Giles; Steven M Haffner; Norman Hollenberg; Willa Hsueh; Ronald Law; Jorge Plutzky; Robert Ratner; Jane Reusch; Andrew Selwyn; James R Sowers; Kathleen L Wyne; Lawrence H Young
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Metabolic syndrome and related disorders 2005;3(2):147-73.
2004: Pallavi R Devchand; Ouliana Ziouzenkova; Jorge Plutzky
Oxidative stress and peroxisome proliferator-activated receptors: reversing the curse?
Circulation research 2004;95(12):1137-9.
2004: Jorge Plutzky
Inflammation in atherosclerosis and diabetes mellitus.
Reviews in endocrine & metabolic disorders 2004;5(3):255-9.
2004: Jorge Plutzky
PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. Introduction.
Clinical cardiology 2004;27(7 Suppl 4):IV1-2.
2004: Ouliana Ziouzenkova; Jorge Plutzky
Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
Current opinion in clinical nutrition and metabolic care 2004;7(4):369-75.
2003: Jorge Plutzky
The vascular biology of atherosclerosis.
The American journal of medicine 2003;115 Suppl 8A():55S-61S.
2003: Jorge Plutzky
Peroxisome proliferator-activated receptors as therapeutic targets in inflammation.
Journal of the American College of Cardiology 2003;42(10):1764-6.
2003: Joshua Beckman; Annaswamy Raji; Jorge Plutzky
Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: issues and opportunities.
Current opinion in cardiology 2003;18(6):479-85.
2003: Jorge Plutzky
Medicine. PPARs as therapeutic targets: reverse cardiology?
Science (New York, N.Y.) 2003;302(5644):406-7.
2003: Ouliana Ziouzenkova; Liana Asatryan; Deanna Sahady; Gabriela Orasanu; Stéphane Perrey; Benjamin Cutak; Tom Hassell; Taro E Akiyama; Joel P Berger; Alex Sevanian; Jorge Plutzky
Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein.
The Journal of biological chemistry 2003;278(41):39874-81.
2003: Jorge Plutzky
The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
The American journal of cardiology 2003;92(4A):34J-41J.
2003: Paul M Ridker; Nancy R Cook; Suzanne Cheng; Henry A Erlich; Klaus Lindpaintner; Jorge Plutzky; Robert Y L Zee
Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(5):859-63.
2003: Jorge Plutzky
Diabetes as a vascular disease. Dyslipidemia as a target.
Postgraduate medicine 2003;113(4 Suppl):15-23.
2003: Ouliana Ziouzenkova; Stéphane Perrey; Liana Asatryan; Juliana Hwang; Karen L Macnaul; David E Moller; Daniel J Rader; Alex Sevanian; Rudolf Zechner; Gerald Hoefler; Jorge Plutzky
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2730-5.
2003: Daniel Kramer; Annaswamy Raji; Jorge Plutzky
Prediabetes mellitus and its links to atherosclerosis.
Current diabetes reports 2003;3(1):11-8.
2002: Peter Libby; Jorge Plutzky
Diabetic macrovascular disease: the glucose paradox?
Circulation 2002;106(22):2760-3.
2002: Jorge Plutzky; Giancarlo Viberti; Steven M Haffner
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
Journal of diabetes and its complications 2002;16(6):401-15.
2002: Annaswamy Raji; Jorge Plutzky
Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.
Current cardiology reports 2002;4(6):514-21.
2002: Sanjeev Sethi; Ouliana Ziouzenkova; Heyu Ni; Denisa D Wagner; Jorge Plutzky; Tanya N Mayadas
Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha.
Blood 2002;100(4):1340-6.
2002: Nikolaus Marx; Bettina Kehrle; Klaus Kohlhammer; Miriam Grüb; Wolfgang Koenig; Vinzenz Hombach; Peter Libby; Jorge Plutzky
PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Circulation research 2002;90(6):703-10.
2002: Ouliana Ziouzenkova; Stéphane Perrey; Niko Marx; DANIEL BACQUEVILLE; Jorge Plutzky
Peroxisome proliferator-activated receptors.
Current atherosclerosis reports 2002;4(1):59-64.
2001: Jorge Plutzky
Inflammatory pathways in atherosclerosis and acute coronary syndromes.
The American journal of cardiology 2001;88(8A):10K-15K.
2001: Nikolaus Marx; P Libby; Jorge Plutzky
Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
Journal of cardiovascular risk 2001;8(4):203-10.
2001: Nikolaus Marx; Nigel Mackman; Uwe Schönbeck; N Yilmaz; Vinzenz Hombach; Peter Libby; Jorge Plutzky
PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
Circulation 2001;103(2):213-9.
2000: Jorge Plutzky
Emerging concepts in metabolic abnormalities associated with coronary artery disease.
Current opinion in cardiology 2000;15(6):416-21.
2000: Jorge Plutzky
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
Current atherosclerosis reports 2000;2(4):327-35.
2000: Nikolaus Marx; F Mach; Alain Sauty; J H Leung; M N Sarafi; R M Ransohoff; Peter Libby; Jorge Plutzky; Andrew D Luster
Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(12):6503-8.
1999: Scott Kinlay; Jorge Plutzky
Effect of lipid-lowering therapy on vasomotion and endothelial function.
Current cardiology reports 1999;1(3):238-43.
1999: Jorge Plutzky
Atherosclerotic plaque rupture: emerging insights and opportunities.
The American journal of cardiology 1999;84(1A):15J-20J.
1999: Nikolaus Marx; Galina K Sukhova; T Collins; Peter Libby; Jorge Plutzky
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.
Circulation 1999;99(24):3125-31.
1999: Nikolaus Marx; todd bourcier; Galina K Sukhova; Peter Libby; Jorge Plutzky
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):546-51.
1998: Nikolaus Marx; Uwe Schönbeck; Mitchell Lazar; Peter Libby; Jorge Plutzky
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Circulation research 1998;83(11):1097-103.
1998: Nikolaus Marx; G Sukhova; C Murphy; Peter Libby; Jorge Plutzky
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
The American journal of pathology 1998;153(1):17-23.
1998: U Laufs; V La Fata; Jorge Plutzky; James K Liao
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
Circulation 1998;97(12):1129-35.
1992: R M Freeman; Jorge Plutzky; Benjamin G Neel
Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(23):11239-43.
1992: Jorge Plutzky; Benjamin G Neel; R D Rosenberg; RL Eddy; M G Byers; S Jani-Sait; TB Shows
Chromosomal localization of an SH2-containing tyrosine phosphatase (PTPN6).
Genomics 1992;13(3):869-72.
1992: Jorge Plutzky; Benjamin G Neel; R D Rosenberg
Isolation of a src homology 2-containing tyrosine phosphatase.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(3):1123-7.